MultiCell Signs Supply Agreement with Lundbeck for MS Candidate
Genetic Engineering News (press release) - New Rochelle,NY,USA
MultiCell Technologies entered into a long-term
agreement with Lundbeck Pharmaceuticals Italy
related to its multiple sclerosis (MS) drug. ...
See all stories on this topic

Genentech Q1 2007 Earnings Call Transcript
Seeking Alpha - New York,NY,USA
We look forward to presenting the results from
the Phase II HERMES study in relaxing and
remitting multiple sclerosis, or RRMS, at
the American Academy of ...
See all stories on this topic

Full Text
Science Magazine (subscription) - USA
A more advanced therapeutic strategy that
has entered human trials is the nonselective
S1P receptor agonist known as FTY720 or
fingolimod, which is being ...
See all stories on this topic